Mobile Menu - OpenMobile Menu - Closed

Connect

Healthcare

I am committed to preserving hard-fought for reforms to our health system.

Affordable Medications 

As the Chair and Founder of the House Affordable Prescription Drug Task Force, I am committed to bringing more oversight and transparency to drug pricing and supporting legislative and administrative solutions so that more families can afford the medicine they need.

High drug prices are not a problem with one pharmaceutical manufacturer, one class of drugs, or one disease—this problem is widespread. While we have made advances in research and treatment, an unaffordable drug is 100 percent ineffective. I have urged President Trump to use the authority he already has to encourage competition that would lower drug prices. Drugs developed with public funding should be available -- and affordable -- to the public. I am also sponsoring multiple pieces of legislation that would allow Medicare to use its purchasing power to lower drug costs for seniors and taxpayers through negotiation, fight anti-competitive pay-for-delay deals, and promote transparency throughout the drug development and pricing process.

Protecting Health Insurance Reform

I remain committed to preserving the hard-fought reforms that provided health insurance to millions through the Affordable Care Act (ACA), resisting those who seek to repeal, defund, or sabotage the ACA. Even President Trump has called the defeated Republican healthcare repeal bill “mean, mean, mean.” I voted against it because it removes protections for people with pre-existing conditions; brings back lifetime and annual caps on care; allows states to remove essential health benefits -- like maternity care and mental health services; and take almost a trillion dollars out of Medicaid.  Most every health care professional group came out to condemn this travesty – I stood with the American Medical Association, the American Hospital Association, the American Cancer Society, March of Dimes, and families around our Nation in opposition to this cruel bill, and will continue to oppose any future efforts to repeal or dismantle the ACA.

Defending Reproductive Rights

I trust women to make their own healthcare decisions, which is why I oppose efforts to block access to comprehensive reproductive care and fully support measures that help protect women’s health. I am a member of the Congressional Pro-Choice Caucus and, consistent with my 100% pro-choice voting record (as evaluated by Planned Parenthood and NARAL Pro-Choice America), I strongly support reproductive rights and oppose efforts to defund comprehensive healthcare clinics.

There is a steady drumbeat to overturn Roe v. Wade and take away a woman’s right to choose—even in the tragic cases of rape, incest, or dangerous health risks. Women in Texas face some of the most extreme barriers in accessing reproductive healthcare in the country. These excessive restrictions are not supported by medical experts—but they do shutter safe, comprehensive clinics and jeopardize women’s health. Instead of focusing on measures that would take important, complex medical decisions away from women, I sponsored the Women's Health Protection Act, which would make unlawful many of the types of politically motivated restrictions that take away a woman's ability to choose quality reproductive care. I also sponsored the Equal Access to Abortion Coverage in Health Insurance (EACH Woman) Act, which protects access to reproductive care for public health insurance beneficiaries, federal employees, and in federal health services.

I have consistently rejected Republicans’ anti-choice amendments and riders on appropriation bills, have strongly opposed Republican efforts to defund Planned Parenthood in their health care repeal bills, and will continue to support efforts to improve access to reproductive services. I will continue working hard to protect a woman’s right to make her own healthcare decisions.

Healthcare for Seniors

For several decades, Social Security and Medicare have been a lifesaving safety net for our seniors, protecting their physical and financial well-being, and providing well-earned peace of mind after a lifetime of work.

Just over fifty years after President Johnson first signed Medicare into law, the program continues to provide necessary health services for so many across our country. As a recent recipient of two national legislative awards from AARP, which recognized my initiaitves on healthcare and efforts to ensure seniors' access to healthcare, I continue working to defend, strengthen and improve Medicare, a pillar of retirement security. The Republican bill to repeal the Affordable Care Act takes billions of dollars out of the Medicare trust funds by giving a major tax windfall to the wealthiest few and to pharmaceutical companies. I have spoken out repeatedly against these giveaways, which come at the expense of our seniors’ care.

Protecting seniors also means protecting them from fraud.  My Medicare Identity Theft Prevention Act, which requires the removal of Social Security numbers from Medicare cards, was enacted into law. With identity thieves becoming increasingly sophisticated, a little prevention can prevent a lot of heartache. Seniors who have worked a lifetime building their financial security deserve better protection.

My AARP-endorsed bipartisan NOTICE Act was signed into law. NOTICE does just what its name suggests: it gives patients notice when they are about to be billed personally after being categorized as "under observation" in the hospital. Currently, a hospital may either admit a patient as an "inpatient" or keep the patient "under observation." While the distinction is often impossible to determine, particularly by the beneficiary, the cost can be extreme if expensive skilled nursing home care is required.

Social Security

Social Security isn’t a Ponzi scheme or a handout. It is one of our most successful initiatives, providing security for tens of millions of seniors. In eight decades, Social Security has never been a day late or a dollar short. It has never contributed a dime to the deficit and has generated a $2.6 trillion surplus. With modest improvements to ensure its long-term solvency, Social Security will be there for our grandchildren.

More on Healthcare

May 13, 2020 Press Release
Washington, D.C. – As the pandemic broadens and the Trump Administration bungles, U.S. Representative Lloyd Doggett (D-TX), Chairman of the Health Subcommittee on Ways and Means, and U.S. Representative Rosa DeLauro (D-CT), Chair of the Labor, Health and Human Services, and Education Appropriations Subcommittee, urge Secretary Azar to create a transparent process for distributing available doses of remdesivir and to swiftly release initial clinical trial findings. For physicians facing difficult prescribing decisions, this information is critical to ensure limited supplies go to the patients who will most benefit. This letter comes following the failure of Secretary Azar yet to respond to the lawmakers’ previous inquiry regarding taxpayer investments in remdesivir.
May 8, 2020 In The News
Now that the Food and Drug Administration has authorized remdesivir for emergency use in seriously ill COVID-19 patients, the experimental drug is another step closer to full approval. That's when most drugs get price tags.
May 6, 2020 Press Release
Austin, T.X. – As the COVID-19 pandemic worsens and many Texans approach two months since job loss—the deadline to enroll in an ACA Marketplace plan for someone who lost their coverage when they lost their job—U.S. Representative Lloyd Doggett (D-TX), Chairman of the House Ways and Means Health Subcommittee, will hold a virtual press conference tomorrow to share the steps consumers need to take (and when to take them) to get covered, local resources available, and important updates on Medicaid.
May 6, 2020 In The News
Gilead has rocketed into the public consciousness with one of the most promising coronavirus treatments, but the company’s history of sky high drug pricing is drawing increasing scrutiny from Congress about how much it will charge for remdesivir and who will get access.
May 6, 2020 In The News
The Justice Department has opened a criminal investigation into Blue Flame Medical, a firm created by two well-connected Republican operatives who started selling medical supplies this spring as the novel coronavirus spread across the country.
May 6, 2020 In The News
Gilead Sciences Inc faces a new dilemma in deciding how much it should profit from the only treatment so far proven to help patients infected with the novel coronavirus.
May 4, 2020 Press Release
Washington, D.C. – Today, U.S. Representative Lloyd Doggett (D-TX), Chairman of the House Ways and Means Health Subcommittee, led Members in urging Gilead CEO Daniel O’Day to detail the company’s plans for remdesivir, including securing and scaling up the supply chain, complete disclosures of taxpayer investment in the development of the drug, and purchase and pricing arrangements. As remdesivir—which has been developed with significant taxpayer investment—receives FDA emergency use authorization, the lawmakers questioned its affordability and accessibility for patients.
March 6, 2020 Press Release
Today, U.S. Representative Lloyd Doggett (D-TX), Chairman of the House Ways and Means Health Subcommittee, released the following statement commending Austin Mayor Adler’s courageous decision to cancel SXSW. Rep. Doggett said:
March 4, 2020 Press Release
Washington, D.C. – U.S. Representative Lloyd Doggett (D-TX), Chairman of the House Ways and Means Health Subcommittee, released the following statement on the emergency coronavirus supplemental appropriations package that the House is set to consider today:
March 2, 2020 In The News
A person once quarantined at Joint Base San Antonio-Lackland but released into the larger community tested “weakly positive” for the virus that causes COVID-19, health officials confirmed Sunday.